NCT06697613View on ClinicalTrials.gov

Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

June 30, 2024

Study Completion Date

August 31, 2024

Conditions

Ovarian CancerAKI - Acute Kidney Injury

Interventions

PROCEDURE

Hyperthermic intraperitoneal chemotherapy

Patients diagnosed with FIGO Stage 3 or stage 4 ovarian cancer received hyperthermic intraperitoneal chemotherapy with cisplatin following cytoreductive surgery including primary debulking surgery, interval debulking surgery and secondary debulking surgery.

Trial Locations (1)

510120

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors

collaborator

The First Affiliated Hospital of Bengbu Medical University

OTHER

lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT06697613 - Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer | Biotech Hunter | Biotech Hunter